Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT)’s traded shares stood at 0.8 million during the last session. At the close of trading, the stock’s price was $8.53, to imply a decrease of -12.33% or -$1.2 in intraday trading. The ZYBT share’s 52-week high remains $14.30, putting it -67.64% down since that peak but still an impressive 58.97% since price per share fell to its 52-week low of $3.50.
Zhengye Biotechnology Holding Ltd (NASDAQ:ZYBT) trade information
After registering a -12.33% downside in the last session, Zhengye Biotechnology Holding Ltd (ZYBT) has traded red over the past five days. The 5-day price performance for the stock is 8.80%, and -19.15% over 30 days. With these gigs, the year-to-date price performance is 75.51%.
ZYBT Dividends
Zhengye Biotechnology Holding Ltd has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Going by data provided on Mar 31, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 8.45 shares. This is just over 0.02% of the total shares, with a market valuation of $72035.0
